Skip to content
Open access

Diosgenin enhances 5-fluorouracil sensitivity in drug-resistant colorectal cancer cells via inhibition of ATR/Chk1-mediated DNA damage response.

Sep 2026 · Cancer Treatment and Research Communications · Vol 49, pp. 101426 · 0 citations · 25 references
Medicine

TL;DR

The findings of this study suggest that diosgenin may contribute to reducing 5-FU resistance by affecting ATR/CHK1-associated DNA damage response mechanisms, weakening DNA repair mechanisms, and suppressing drug efflux pumps.

Abstract

Background

AND

Objective

Drug resistance to 5-fluorouracil (5-FU) is one of the major challenges in the treatment of colorectal cancer, which is largely associated with the activation of DNA damage response (DDR) pathways, especially the ATR-CHK1 axis, and increased activity of drug efflux pumps. The aim of this study was to investigate the effect of diosgenin, a natural anticancer compound, alone and in combination with an ATR inhibitor (VE-822), on sensitizing 5-FU-resistant colorectal cancer cells and to elucidate the molecular mechanisms involved in this process.

Methods

In this in vitro study, human colorectal cancer cell line Caco-2 and a 5-FU-resistant line (Caco-2/5-FU) were used. Cell viability and proliferation were assessed by MTT and trypan blue assays, and the ability of long-term cell proliferation was examined by colony formation assay. The expression of genes associated with drug resistance (MDR1/P-gp, ABCG2, ABCC1, YB-1), DNA damage response pathway (ATR, CHK1, H2AX) and apoptosis (Bax, Bcl-2, Caspase-3, PARP-1) was measured by qRT-PCR. The level of DNA damage was assessed by examining the γ-H2AX protein with Western blot. The function of the P-gp pump was measured by the rhodamine 123 accumulation assay and the level of apoptosis was measured by the DNA fragment detection ELISA kit. The cells were treated with diosgenin, VE-822, 5-FU and their double and triple combinations.

Results

The results showed that the IC50 of 5-FU in resistant Caco-2/5-FU cells was significantly higher than in sensitive cells, indicating the development of a drug resistance phenotype. Diosgenin alone was able to significantly reduce the viability of both sensitive and resistant cells, although resistant cells showed a lower response. Inhibition of ATR with VE-822 significantly reduced cell viability, and the combination of diosgenin with VE-822 in the presence of 5-FU produced a stronger combined effect and significantly reduced the IC50. Trypan blue and colony formation assays showed a severe reduction in cell survival and long-term proliferation in the combination treatment. Molecularly, the combination treatment significantly inhibited the expression and function of P-gp and reduced the expression of MDR1, ABCG2, ABCC1 and YB-1 genes. The expression of ATR and CHK1, as well as γ-H2AX protein expression levels was also significantly reduced. The Bax/Bcl-2 ratio was increased, and the expression of Caspase-3 and PARP-1 was significantly increased. ELISA results also confirmed a significant increase in apoptosis, especially in the triple treatment of diosgenin+VE-822+5-FU.

Conclusion

The findings of this study suggest that diosgenin may contribute to reducing 5-FU resistance by affecting ATR/CHK1-associated DNA damage response mechanisms, weakening DNA repair mechanisms, and suppressing drug efflux pumps. The combination of diosgenin with an ATR inhibitor may have a strong combined effect in inducing DNA damage, inhibiting drug resistance, and promoting apoptosis-associated molecular changes. This combination approach may represent a potential chemosensitizing approach for further investigation in colorectal cancer; however, additional validation in diverse models and in vivo studies is required.

Read PDF

Similar papers

Open access Sep 2026

Levofloxacin enhances 5-fluorouracil efficacy in colorectal cancer by activating the DDR-TP53-mitochondrial apoptosis axis

Summary 5-Fluorouracil (5-FU)-based regimens are a cornerstone of colorectal cancer (CRC) chemotherapy. Levofloxacin (LVF), a widely used fluoroquinolone antibiotic, has been reported to exhibit anticancer properties. We investigated LVF’s ability to enhance CRC chemosensitivity to 5-FU in cell lines, subcutaneous xeno...

Chen-Meng Huang, Chen-Chen Sun, Han Wang et al. · 0 citations
Open access Sep 2026

RIPK3 overcomes 5-fluorouracil resistance in colorectal cancer cells via AKT/mTOR-mediated autophagy

RIPK3 enhances the sensitivity of colorectal cancer cells to 5-FU and increases the efficacy of 5-FU in inhibiting cell proliferation, invasion, and migration by activating cellular autophagy through inhibition of the AKT-mTOR signaling pathway, thereby reversing drug resistance in colorectal cancer cells.

Biao Wang, Xiao-Tong An, Wei-Hua Fu · 0 citations
Open access Oct 2026

Curcumin Enhances the Sensitivity of 5-fluorouracil-resistant Colon Cancer Cells to 5-fluorouracil Through a Ferroptosis-related Mechanism: A Network Pharmacology and In Vitro Study

Colorectal cancer (CRC) is a common and deadly malignancy. Although 5-fluorouracil (5-FU) continues to be a standard therapeutic agent for CRC, the development of resistance substantially compromises its clinical effectiveness. Curcumin, a natural polyphenol, has shown potential in reversing chemoresistance, possib...

Wei Hao, Bang-Wei Cao, Lei Han · 0 citations
Aug 2026

Malformin A1 Enhances 5-Fluorouracil-induced Apoptosis, Cell Cycle Arrest, and Anti-angiogenesis in Colorectal Cancer Cells

Background/Aim: Malformin A1 (MA1), a fungal-derived cyclic pentapeptide, has been reported to exhibit anti-cancer activity. 5-fluorouracil (5-FU) is a widely used chemotherapeutic agent that inhibits DNA and RNA synthesis and suppresses colorectal cancer (CRC) cell growth. This study aimed to investigate whether MA1 e...

Je-Seong Kim, Chan-Muk Im, Hyung-Hoon Oh et al. · 0 citations
Sep 2026

A novel dihydroisoxazole derivative DHI9 suppresses colorectal cancer cell survival by inducing oxidative stress, DNA damage, and mitochondrial apoptosis while targeting Akt and Wnt/β-catenin signalling.

Dihydroisoxazole derivative DHI9 modulated selected proteins involved in Wnt/β-catenin and Akt signalling pathways, apoptosis, and cell cycle regulation, and enhanced the cytotoxic activity of 5-fluorouracil, with predominantly synergistic interactions according to the Highest Single Agent model.

Simona Žiláková, Dominika Varcholova, Viktória Medvecová et al. · 0 citations
Open access Oct 2026

Chk1/2 Inhibition by AZD7762 Enhances Andrographolide-Induced DNA Damage, Impairs DNA Repair, and Promotes Apoptosis in Head and Neck Squamous Cell Carcinoma CAL-33 Cells

Background: Andrographolide (AG), a diterpenoid lactone and a major constituent of Andrographis paniculata, has shown promising antiproliferative effect on diverse cancer cell lines, including head and neck cancer. However, a significant anti-proliferative effect is observed only at high micromolar concentrations. Furt...

Sakshi Singh, Anitha Kartha, Aishwarya Jaiswal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.